A collection of news and information related to IMS Health Incorporated published by this site and its partners.
Displaying items 1-12 of 42 » View wsbtradio.com items only1 2 3 4 Next >
ReutersLOS ANGELES (Reuters) - After decades of using one-size-fits-all therapies to combat cancer, doctors are using new tools to help decide when their patients can skip chemotherapy or other harsh treatments. An approach to oncology that has been in place...
Reuters(For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) By Bill Berkrot NEW YORK, May 6 (Reuters) - Teva Pharmaceutical Industries Ltd has yet to make any serious inroads into China, but its chief executive...
With a federal judge clearing away age restrictions on purchasing emergency contraception, many Chicago-area health care providers, teens and others are preparing for more accessibility — even if they're not exactly sure how the drug will be made...
ReutersApril 26 (Reuters) - Generic drugmaker Actavis Inc said it had settled a patent lawsuit with Purdue Pharma related to Actavis' generic version of the abuse-deterrent formulation of Purdue's painkiller OxyContin. Under the agreement, Actavis will be...
ReutersNEW YORK (Reuters) - A federal judge on Friday ordered the U.S. Food and Drug Administration to make "morning-after" emergency contraception pills available without a prescription to all girls of reproductive age and criticized the Obama administration...
A new study suggests that the 6% to 10% of Americans who use prescription sleep medications such as zolpidem (Ambien), temazepam (Restoril), eszopiclone (Lunesta) and zaleplon (Sonata) are more likely to develop cancer, and far more likely to die...
WASHINGTON (AP) -- Federal health regulators are leaning toward adding new information about the risk of blood clots to the labels of widely prescribed birth control pills such as Yaz, in light of growing evidence suggesting the newer contraceptive...
HealthThe nation's largest-selling pharmaceutical is going generic this week. Lipitor, which is prescribed to help people reduce their cholesterol levels, is going "off-patent" Wednesday. According to a HealthDay News report, Lipitor sales were nearly $4...
Guest columnistThe U.S. Supreme Court has given us two terms of remarkable support for free expression — in cases remarkable for speech that many, if not most, of us really, really dislike. And its ruling June 27 that the states cannot forbid the sale or rental of...
The cost of prescription medicines used by millions of people every day is about to plummet. The next 14 months will bring generic versions of seven of the world’s 20 best-selling drugs, including the top two: cholesterol fighter Lipitor and...
Tags: Companies and Corporations, Insurance, Blood, New York, Business
May 15, 2013 |Story| Reuters
May 6, 2013 |Story| Reuters
Apr 24, 2013 |Story| Chicago Tribune
Apr 26, 2013 |Story| Reuters
Apr 5, 2013 |Story| Reuters
Feb 28, 2012 |Story| Los Angeles Times
Jan 10, 2012 |Story| Los Angeles Times
Feb 2, 2012 |Story| South Florida Sun-Sentinel
Dec 6, 2011 |Story| Petoskey News
Nov 29, 2011 | Allentown Morning Call
Jul 13, 2011 |Story| Jessamine Journal
Jul 24, 2011 |Story| Aberdeen News
Original site for IMS Health Incorporated topic gallery.